Supplement × Prescription·a synergy·Moderate evidence
Hypokalemia increases QT-related arrhythmia risk during ziprasidone therapy.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
What is happening. Hypokalemia increases QT-related arrhythmia risk during ziprasidone therapy.
Mechanism. Normal potassium levels reduce vulnerability to delayed repolarization and torsades.
Recommendation. Correct low potassium medically; avoid unsupervised potassium supplementation in kidney disease or with potassium-retaining drugs.
Effect on the composite score
If both Potassium and Ziprasidone are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
Every claim on this page is cited. PMIDs link straight to PubMed.
Check your full routine
Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack